230 related articles for article (PubMed ID: 25193624)
1. A new dimeric neolignan from Magnolia grandiflora L. seeds.
Li HM; Zhao SR; Huo Q; Ma T; Liu H; Lee JK; Hong YS; Wu CZ
Arch Pharm Res; 2015 Jun; 38(6):1066-71. PubMed ID: 25193624
[TBL] [Abstract][Full Text] [Related]
2. Magnolia dealbata seeds extract exert cytotoxic and chemopreventive effects on MDA-MB231 breast cancer cells.
Alonso-Castro AJ; Domínguez F; García-Regalado A; González-Sánchez I; Cerbón MA; García-Carrancá A
Pharm Biol; 2014 May; 52(5):621-7. PubMed ID: 24400594
[TBL] [Abstract][Full Text] [Related]
3. Substituted dineolignans from Magnolia garrettii.
Schuehly W; Voith W; Teppner H; Kunert O
J Nat Prod; 2010 Aug; 73(8):1381-4. PubMed ID: 20677809
[TBL] [Abstract][Full Text] [Related]
4. Biphenyl-Type Neolignan Derivatives from the Twigs of Magnolia denudata and Their Anti-Inflammatory Activity.
Chung CY; Kuo WL; Hwang TL; Chung MI; Chen JJ
Chem Biodivers; 2015 Aug; 12(8):1263-70. PubMed ID: 26265578
[TBL] [Abstract][Full Text] [Related]
5. Novel histone deacetylase inhibitors derived from Magnolia officinalis significantly enhance TRAIL-induced apoptosis in non-small cell lung cancer.
Liu Y; Tong Y; Yang X; Li F; Zheng L; Liu W; Wu J; Ou R; Zhang G; Hu M; Liu Z; Lu L
Pharmacol Res; 2016 Sep; 111():113-125. PubMed ID: 27268146
[TBL] [Abstract][Full Text] [Related]
6. Bioactive Neolignans and Other Compounds from Magnolia grandiflora L.: Isolation and Antiplasmodial Activity.
Latif A; Du Y; Dalal SR; Fernández-Murga ML; Merino EF; Cassera MB; Goetz M; Kingston DGI
Chem Biodivers; 2017 Sep; 14(9):. PubMed ID: 28621040
[TBL] [Abstract][Full Text] [Related]
7. Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer.
Tang H; Zhang Y; Li D; Fu S; Tang M; Wan L; Chen K; Liu Z; Xue L; Peng A; Ye H; Chen L
Eur J Med Chem; 2018 Aug; 156():190-205. PubMed ID: 30006164
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic lignans from the stem bark of Magnolia officinalis.
Youn UJ; Chen QC; Jin WY; Lee IS; Kim HJ; Lee JP; Chang MJ; Min BS; Bae KH
J Nat Prod; 2007 Oct; 70(10):1687-9. PubMed ID: 17918910
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of new compounds bearing 3-(4-aminopiperidin-1-yl)methyl magnolol scaffold as anticancer agents for the treatment of non-small cell lung cancer via targeting autophagy.
Zhao M; Zheng YH; Zhao QY; Zheng W; Yang JH; Pei HY; Liu L; Liu KJ; Xue LL; Deng DX; Wang L; Ma X; Fu SH; Peng AH; Tang MH; Luo YZ; Ye HY; Chen LJ
Eur J Med Chem; 2021 Jan; 209():112922. PubMed ID: 33069436
[TBL] [Abstract][Full Text] [Related]
10. Biphenyl-type neolignans from stem bark of Magnolia officinalis with potential anti-tumor activity.
Ni HF; Cai X; Qiu X; Liu L; Ma X; Wan L; Ye H; Chen L
Fitoterapia; 2020 Nov; 147():104769. PubMed ID: 33152462
[TBL] [Abstract][Full Text] [Related]
11. Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction.
Hahm ER; Arlotti JA; Marynowski SW; Singh SV
Clin Cancer Res; 2008 Feb; 14(4):1248-57. PubMed ID: 18281560
[TBL] [Abstract][Full Text] [Related]
12. Isolation of anti-Saprolegnia lignans from Magnolia officinalis and SAR evaluation of honokiol/magnolol analogs.
Hu Y; Shen Y; Tu X; Wu X; Wang GX; Ling F
Bioorg Med Chem Lett; 2019 Feb; 29(3):389-395. PubMed ID: 30579792
[TBL] [Abstract][Full Text] [Related]
13. Modulation of P-glycoprotein expression by honokiol, magnolol and 4-O-methylhonokiol, the bioactive components of Magnolia officinalis.
Han HK; Van Anh LT
Anticancer Res; 2012 Oct; 32(10):4445-52. PubMed ID: 23060571
[TBL] [Abstract][Full Text] [Related]
14. Two new lignans from the stem bark of Magnolia obovata and their cytotoxic activity.
Youn U; Chen QC; Lee IS; Kim H; Yoo JK; Lee J; Na M; Min BS; Bae K
Chem Pharm Bull (Tokyo); 2008 Jan; 56(1):115-7. PubMed ID: 18175990
[TBL] [Abstract][Full Text] [Related]
15. Neolignans from the fruits of Magnolia obovata and their inhibition effect on NO production in LPS-induced RAW 264.7 cells.
Seo KH; Lee DY; Lee DS; Park JH; Jeong RH; Jung YJ; Shrestha S; Chung IS; Kim GS; Kim YC; Baek NI
Planta Med; 2013 Sep; 79(14):1335-40. PubMed ID: 23970426
[TBL] [Abstract][Full Text] [Related]
16. Bioactive polar compounds from stem bark of Magnolia officinalis.
Yu SX; Yan RY; Liang RX; Wang W; Yang B
Fitoterapia; 2012 Mar; 83(2):356-61. PubMed ID: 22155594
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis-inducing and antitumor activity of neolignans isolated from Magnolia officinalis in HeLa cancer cells.
Youn UJ; Fatima N; Chen QC; Chae S; Hung TM; Min BS
Phytother Res; 2013 Sep; 27(9):1419-22. PubMed ID: 23192855
[TBL] [Abstract][Full Text] [Related]
18. The cytotoxicity of 8-O-4' neolignans from the seeds of Crataegus pinnatifida.
Huang XX; Zhou CC; Li LZ; Li FF; Lou LL; Li DM; Ikejima T; Peng Y; Song SJ
Bioorg Med Chem Lett; 2013 Oct; 23(20):5599-604. PubMed ID: 23999046
[TBL] [Abstract][Full Text] [Related]
19. Magnolol and honokiol account for the anti-spasmodic effect of Magnolia officinalis in isolated guinea pig ileum.
Chan SS; Zhao M; Lao L; Fong HH; Che CT
Planta Med; 2008 Mar; 74(4):381-4. PubMed ID: 18484527
[TBL] [Abstract][Full Text] [Related]
20. Identification of antitumor lignans from the seeds of morning glory (Pharbitis nil).
Kim KH; Woo KW; Moon E; Choi SU; Kim SY; Choi SZ; Son MW; Lee KR
J Agric Food Chem; 2014 Aug; 62(31):7746-52. PubMed ID: 25020073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
